SBIO Top Holdings & Constituents
SBIO, offered by SS&C, holds 89 reported positions across $201.6M in assets. Its largest holdings are Alkermes Plc (ALKS) (4.48%), Kymera Therapeutics Inc (KYMR) (4.23%), and Celcuity Inc (CELC) (3.92%). The 5 biggest positions account for 20.21% of reported assets. The table below lists every reported holding with its portfolio weight and market value in US dollars — open any constituent to research its own performance.
| Position | Weight | Market Value |
|---|---|---|
ALKS Alkermes Plc | 4.48% | $7.24M |
KYMR Kymera Therapeutics Inc | 4.23% | $6.85M |
CELC Celcuity Inc | 3.92% | $6.34M |
MIRM Mirum Pharmaceuticals Inc | 3.90% | $6.31M |
SYRE Spyre Therapeutics Inc | 3.68% | $5.95M |
Holdings data comes from the latest SEC Form N-PORT-P filing for this fund, covering the reporting period ended May 31, 2026. Market values are reported in US dollars, and each weight represents the position's share of reported fund assets. Cash, derivatives, and rounding can mean displayed weights do not total 100%. Funds rebalance and file on a schedule, so this page may not reflect intraday or post-filing changes.